School of Medicine
Showing 4,401-4,450 of 4,866 Results
-
Jason V. Tso, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Tso is a board-certified cardiologist with the Sports Cardiology Program and the Center for Inherited Cardiovascular Disease. He serves as medical director of the Sports Cardiology Program and is a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine.
As a noninvasive cardiologist with clinical expertise in sports cardiology, Dr. Tso specializes in treating physically active patients. He cares for recreational weekend warriors, elite and professional athletes, and all those in between.
He has experience caring for athletes from professional sports teams and multiple National Collegiate Athletic Association (NCAA) Division I universities. Dr. Tso currently performs cardiac screening and consultations for Bay Area professional sports teams and the NCAA Division I athletes of Stanford University Athletics.
Dr. Tso’s research interests include cardiovascular health and adaptation in athletes. He has spent years studying American-style football players and Masters endurance athletes. He has presented his research at multiple national meetings, including the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions, and the national meeting of the Heart Failure Society of America.
Dr. Tso’s research has been published in multiple peer-reviewed journals, including the Journal of the American Heart Association, the European Journal of Preventive Cardiology, and the British Journal of Sports Medicine. He also regularly serves as a reviewer for several cardiology and sports medicine journals. -
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone MD, PhD is an Assistant Professor with Stanford School of Medicine’s Department of Psychiatry and Behavioral Sciences. As a neuroscientist, he leads a lab interested in biological mechanisms of mental illness and investigating new therapies for mood disorders and addiction. In particular, he is defining new cell types and evolutionary conserved circuits in emotional processing centers of the brain, with the hope of finding new entry points for novel therapeutics. Working with Dr Robert Malenka, he is using optogenetic, chemogenetic, neuroimaging and behavioral approaches in mouse models of addiction to uncover vulnerable brain circuitry in opioid use disorder. Alongside Dr Alan Schatzberg, he is investigating the efficacy of buprenorphine augmentation to IV ketamine infusion at reducing suicidality in treatment resistant depression.
Clinically, he works collaboratively in the department’s Neuropsychiatry clinic and his clinical focus includes treating patients with diverse and complex presentations at the interface of psychiatry and neurology with particular interest in functional neurological disorders. He sees a small cohort of psychotherapy patients in Individual Psychotherapy Clinic. He also works weekend shifts on Stanford’s inpatient psychiatry units.
Prior to training in psychiatry at Stanford’s research residency track Jason received his bachelor’s degree in biology and philosophy from Union College. He spent three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke investigating and developing MRI reportable contrast agents to map neuronal connectivity. Following this he entered the Medical Scientist Training Program (MD/PhD) at the State University of NY Stony Brook University. There he completed a doctoral dissertation in neuroscience under the mentorship Dr. Josh Huang at Cold Spring Harbor Laboratory. His thesis work employed mouse genetic dissections of excitatory and inhibitory cortical circuits with a focus on the circuitry of chandelier inhibitory interneurons in prefrontal cortex.
In addition to his research and clinical work, Jason is passionate about teaching, mentorship, and resident clinical supervision. He joined a working group early in his clinical residency to restructure trainee’s neuroscience education. He teaches introductory lectures in the neuroscience of addiction, PTSD, psychosis, and mood disorders. He also leads resident group supervision in their introductory psychodynamic psychotherapy clinical experience. He supervises medical students, residents, and clinical fellows in Neuropsychiatry clinic. Finally, committed to the Stanford clinical community, he leads a support group for Internal Medicine interns and residents. -
Jamie Tung, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Tung is a fellowship-trained surgeon in the Stanford Health Care Chest Wall Surgery Program. He is a clinical instructor in the Stanford Medicine Department of Surgery.
His areas of expertise include trauma, general, and critical care surgery. He excels at the surgical treatment of chest wall injury, including stabilization of rib fractures.
In his research, Dr. Tung has investigated gastrotomy tube complications. He has participated in the American Association for the Surgery of Trauma study of the surgical treatment of liver injury. Other research interests include massive transfusion strategies and education regarding pre-hospital trauma management.
Dr. Tung has co-authored articles on complications of hernia surgery and other topics. His work has been published in The Journal of Trauma and Acute Care Surgery and Case Reports in Surgery. He also co-authored a chapter on chest wall surgery in the Textbook of Emergency General Surgery.
Dr. Tung has made presentations at the American College of Surgeons Annual Meeting, Academic Surgical Congress, and other conferences. Topics include massive transfusions, prehospital trauma care, burn resuscitation, and complications of percutaneous endoscopic gastrostomy (PEG) in trauma patients.
He is a member of the American College of Surgeons, Chest Wall Injury Society, Eastern Association for the Surgery of Trauma, and Association for Academic Surgeons. He is a member of the Stanford Medicine Trauma Committee and other committees. He has worked as and is a certified emergency medical technician (EMT) as well as a tactical physician. He also has served as a “Stop the Bleed” instructor with Stanford Medicine as well as with other institutions where he practiced previously.
Dr. Tung is fluent in English and Cantonese. He is proficient in Mandarin. -
Minang (Mintu) Turakhia
Clinical Professor, Medicine
Current Research and Scholarly InterestsDr. Turakhia has an active clinical research program, with funding from AHA, VA, NIH, the medical device industry, and foundations. His research program aims to improve the treatment of heart rhythm disorders, with an emphasis on atrial fibrillation, by evaluating quality and variation of care, comparative and cost-effectiveness of therapies, and risk prediction. Dr. Turakhia has extensive expertise in using large administrative and claims databases for this work. His TREAT-AF retrospective study of over 500,000 patients with newly-diagnosed AF is the largest known research cohort of AF patients. He has served as study PI or chairman of several prominent single- and multicenter trials in atrial fibrillation, investigational devices for electrophysiology procedures, digital health interventions, and sensor technologies.
His other research interests include technology assessment of new device-based therapies and the impact of changing health policy and reform on the delivery of arrhythmia care. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society. -
Nichole Tyson MD
Clinical Professor, Obstetrics & Gynecology
Clinical Professor (By courtesy), PediatricsBioNichole Tyson MD is a Clinical Professor of Obstetrics and Gynecology at Stanford University School of Medicine. She specializes in Pediatric and Adolescent Gynecology (PAG). For over 20 years, Dr. Tyson has partnered with girls and their families as they journey from childhood through adolescence and into adulthood. Dr. Tyson enjoys solving complex problems as well as common concerns that can be overlooked and challenging to girls and young women. She is been recognized locally, nationally and internationally a leader in the field and skilled and experienced surgeon caring for patients with endometriosis, adnexal masses and variations in urogenital anatomy.
As a Pediatric and Adolescent Gynecologist, she specializes in problems such as abnormal periods, hormone management and adolescent contraception in people with underlying medical conditions, pelvic masses, differences of sex development and complex utero-vaginal anatomy.
She has been a leader on a number of national medical committees, including Vice President of the North American Society of Pediatric and Adolescent Gynecology (NASPAG), immediate past-chair of the American Association of Gynecologic Laparoscopy (AAGL) Pediatric and Adolescent Gynecology special interest group and associate member of the Contraception Committee for the International Federation of Gynecology and Obstetrics (FIGO). She is an active contributor to the peer reviewed literature in pediatric and adolescent gynecology, obstetrics and gynecology, contraception and laparoscopic surgery. Dr. Tyson also has extensive experience with the consumer press as an adolescent gynecology expert for numerous online articles in such magazines as Seventeen, Self and NY Times.
She is the Chief of Pediatric and Adolescent Gynecology at Stanford Children's Hospital and the Director of Mentorship and Coaching for the Ob/Gyn Department. She is passionate about teaching, mentorship and coaching, working closely with medical students, residents and fellows. She is an innovator in education, both developing and and implementing numerous curricula in Gynecology, Pediatric Adolescent Gynecology, Simulation education, Surgical Coaching and Leadership and Professionalism. She is currently working as a chief editor for two PAG textbooks-one titled PAG essentials and the other, the first ever PAG surgical textbook, both due for publication in 2024-2025. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Maxine Umeh Garcia
Instructor, Neurosurgery
BioMaxine was born and raised in Sacramento, CA and transferred to UC Merced in 2007 after attending a community college for 2 years. She received her B.S. in Developmental Biology with a minor in Psychology in 2010. During the last year of her undergrad, Maxine was invited to do research in the lab of Dr. Michael Cleary, studying nervous system development. Because of this research experience, Maxine decided to stay at UC Merced to pursue her Master’s in Quantitative and Systems Biology, graduating in 2013. Immediately after graduating, she started her Ph.D. at UC Davis, where her research centered on triple negative breast cancer – a type of breast cancer that has a high incidence in Black and African women.
After completing her PhD in Biochemistry, Molecular, Cell and Developmental Biology with an emphasis in Translational Research in 2019, Maxine became a postdoctoral fellow at Stanford University in the department of Neurosurgery. Dr. Umeh Garcia’s research focuses on breast cancers that metastasize (or travel) to the brain. Maxine was recently promoted to an instructor position in her department after receiving a major career development award from the National Cancer Institute (K99/R00), which will fund the remainder of her postdoctoral research and provide 3 years of funding for Maxine to establish her own independent research lab. Using her background in bench research, informatics, and translational research, Dr. Umeh Garcia hopes to bring together biologists, data scientists, and clinicians to make important advances in breast cancer diagnosis and treatment. Additionally, as a women and underrepresented minority, Dr. Umeh Garcia is keenly interested in mentoring women and underrepresented students, and in developing novel strategic approaches to increasing diversity in biomedical sciences and academic research. -
Ndidi Unaka
Clinical Professor, Pediatrics
BioDr. Unaka is the inaugural Chief Health Equity Officer (CHEO) for Stanford Medicine Children’s Health (SMCH) and a Clinical Professor in the Department of Pediatrics at Stanford University School of Medicine. Prior to her transition to SMCH in July 2024, Dr. Unaka was a faculty member in the Division of Hospital Medicine at Cincinnati Children's Hospital. In addition to her clinical role as a pediatric hospitalist, Dr. Unaka served as the Associate Program Director of the Pediatric Residency Program from 2011 – January 2022. She served as the medical director of a 48- bed inpatient unit primarily for patients admitted to the Hospital Medicine service. In this role, Dr. Unaka was involved in several equity-oriented quality improvement initiatives which included work to identify, and address hunger among caregivers of hospitalized children insured by Medicaid.
Dr. Unaka worked on institution-level community health initiatives at Cincinnati Children’s. She served as the Medical Director of Quality Improvement and Data Analytics for Cincinnati Children’s Medicaid- focused, accountable care organization (HealthVine). In this role, she developed and led initiatives designed to improve the quality and efficiency of health care delivery to HealthVine’s patient population and helped lead the change management associated with the movement toward a population-health care model that improves quality, narrows equity gaps, streamlines care, and reduces costs. She helped define appropriate health care delivery, equity, and population health measures and quality benchmarks. Additionally, Dr. Unaka was a faculty lead within Cincinnati Children's Fisher Child Health Equity Center, and she specifically focused on working with operations leaders to ensure equity was embedded within all strategic plans, goals, and metrics across all sites of care. Dr. Unaka partnered with several colleagues to lead system-wide quality improvement initiatives including work accelerated via learning networks. She was the co-lead of Cincinnati Children's Health Equity Network (HEN), an initiative borne out of the pursuit of excellent and equitable health outcomes for youth in Greater Cincinnati. The HEN supports clinical teams seeking to eliminate disparities in child health outcomes by race, ethnicity, and/or socioeconomic status via targeted interventions and best practices by addressing both medical and social factors known to confer poor health outcomes. -
Crystal Unzueta, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Unzueta is a board-certified family medicine physician. She specializes in providing primary care services to people of all ages. Her services include annual check-ups, monitoring chronic conditions, and performing minor in-office procedures.
She is also a clinical assistant professor in the Stanford School of Medicine Department of Family Medicine.
Dr. Unzueta’s practice focuses on providing compassionate and comprehensive care. She specializes in providing bilingual and bicultural care for patients in underserved populations. She has traveled to Belize on a medical mission to provide free, basic primary care to vulnerable communities. Her mentoring work includes building a network of Latino medical students to help support each other throughout medical school. She has also worked on numerous volunteer projects, such as researching the benefits of a community yoga program for minorities in underserved areas. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
PJ Utz
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
-
Sivakamasundari V
Instructor, Institute for Stem Cell Biology and Regenerative Medicine
BioMy research interests are focused on understanding the molecular basis of early development and stem cells, as it is often aberrations in stem cells or signaling mechanisms between tissues that lead to diseased states, including tumor development and cancer progression. Knowledge of stem cells and development is also critical to develop appropriate cell-based therapies for various diseases or injuries. My prior and current works take advantage of both traditional techniques (gene targeting, lineage tracing) and state-of-the-art technologies (Single cell RNA sequencing, Chromatin Immunoprecipitation (ChIP-seq), Imaging Mass Cytometry) to elucidate fundamental molecular mechanisms underlying signaling in tissue biology.
-
Randall Vagelos, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions. -
Sharif Vakili, MD, MBA, MS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSharif Vakili, MD, MBA, MS, (pronouns: he/him), is an internal medicine physician and educator. He practices at Stanford Los Altos Primary Care.
Dr. Vakili has a background in chronic disease management and health systems delivery, believing strongly in a teamwork approach to patient care that empowers patients to navigate the health system as part of their clinical care.
He is active in the research and business communities. His research has been in peer-reviewed journals including JAMA Network Open, the Annals of Emergency Medicine, Quality Management in Healthcare, and Journal of Clinical Rheumatology.
Dr. Vakili is also the inventor of Remote Patient Intervention (RPI), a model of clinician-supervised AI care delivery first performed at Stanford during a clinical study published in JAMA Network Open. -
Hannah Valantine
Professor of Medicine (Cardiovascular)
On Leave from 09/01/2024 To 08/31/2025Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.
-
Tulio Valdez, MD, MSc
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioDr. Tulio A Valdez is a surgeon scientist born and raised in Colombia with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children’s Hospital (2007), Houston and obtained his Master’s in Clinical and Translational Research at the University of Connecticut.
Clinically, Dr. Valdez has an interest in pediatric sleep apnea. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.
Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at the Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure.
Dr. Valdez believes in multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models. -
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Laurent D Valosek
Academic Staff - Hourly - CSL, Medicine
BioMr. Valosek has 35 years of experience as an entrepreneur, educator and researcher. He was co-founder and CEO of Integrated Devices LLC, a wireless engineering consulting firm, Xistor Technology Development Corporation, a semiconductor intellectual property company, and Sophia Communications, a wireless technology development and wide area network service provider. He also co-founded a strategy and business development consulting firm, Lakshmi Technologies, with partners from the Boston Consulting Group and Deloitte, focused on providing services to early stage high technology companies. Mr. Valosek has extensive experience in the areas of strategy, planning, recruiting, training, business development and general management.
In addition to his business expertise, Mr. Valosek has a long standing interest in the role of human development as it relates to health, education, organizational effectiveness and social transformation. He helped conduct NIH-funded research on meditation and heart health at the West Oakland Health Center and ADHD research with middle school students in the Albany Unified School District. He co-founded the Center for Wellness and Achievement in Education in 2007, for the purpose of providing evidence-based wellness programs to students, schools, school districts and other community organizations. -
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
-
Pieter van der Starre
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
Neurophysiology and Monitoring,
Transesophageal Echocardiography -
Keith Van Haren, MD
Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
-
Peter Johannes van Roessel
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Vance Vanier, M.D.
Clinical Assistant Professor, Emergency Medicine
Current Research and Scholarly InterestsPrimary and secondary prevention of disease through the use of preventive genomic medicine. Patients who have greater insight into their genetic risk for different diseases may change their lifestyles and decrease their probablity of succumbing to conditions such as diabetes and cardiovascular events. Personalized screening regimens for those at increased genetic risk, such as for colon cancer, is another important application worthy of validation.
